title: A 24-month dietary carcinogenicity study of DAG (diacylglycerol) in rats.
abstract: Toxicologic and carcinogenic effects of DAG (diacylglycerol) oil, administered in diet for 24 months to Crl:CD((R))(SD)-IGS BR rats, were evaluated using diet-restricted and ad libitum-fed groups. All dietary fat (consistently 5.5%) was provided by DAG and/or the control article, TG (triacylglycerol) oil. Dietary concentrations (% DAG/% TG) were 0%/5.5%, 1%/4.5%, 2.75%/2.75% and 5.5%/0%. Separate groups were fed the 0%/5.5% and 5.5%/0% diets ad libitum. Another group received the standard rodent diet (fat content 4.5%) on the restricted feeding regimen. Clinical condition, ophthalmic findings, palpable mass occurrence, body composition, clinical pathology parameters and incidence of neoplastic lesions were unaffected by DAG in comparison to TG. Groups fed the 5.5% (DAG and/or TG) fat diet when compared to the 4.5% fat diet group displayed lower survival, higher body weights, organ weights, percent body fat, higher fat-related serum chemistry parameters, incidence of microscopic changes in the heart, kidneys, liver, bone marrow, spleen, and incidences of pituitary and mammary gland neoplasms. Parameters more affected in all the ad libitum groups than in the restricted diet groups (regardless of test article) fed the same diet included survival, body weights, body fat, fat-related serum chemistry parameters, and incidences of heart, kidney and liver microscopic changes. However, the DAG and TG ad libitum-fed groups were not different from one another. Thus, DAG-treated animals had no higher risk of carcinogenic effects than rats fed on similar feeding regimens with a diet in which all dietary fat came from TG.
authors.affiliation: WIL Research Laboratories, LLC, Ashland, OH 44805-9281, USA. chengelis@wilresearch.com
authors.forename: Christopher P
authors.initials: CP
authors.lastname: Chengelis
authors.forename: Jeannie B
authors.initials: JB
authors.lastname: Kirkpatrick
authors.forename: Richard H
authors.initials: RH
authors.lastname: Bruner
authors.forename: Les
authors.initials: L
authors.lastname: Freshwater
authors.forename: Osamu
authors.initials: O
authors.lastname: Morita
authors.forename: Yasushi
authors.initials: Y
authors.lastname: Tamaki
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Suzuki
mesh_terms: D000284:Administration, Oral; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D015197:Carcinogenicity Tests; D002273:Carcinogens / Q000145:classification / Q000633:toxicity*; D004032:Diet; D004075:Diglycerides / Q000737:chemistry / Q000145:classification / Q000633:toxicity*; D004305:Dose-Response Relationship, Drug; D004435:Eating / Q000187:drug effects; D005227:Fatty Acids / Q000032:analysis; D005260:Female; D005508:Food Deprivation; D008136:Longevity / Q000187:drug effects; D008297:Male; D019055:No-Observed-Adverse-Effect Level; D009929:Organ Size / Q000187:drug effects; D051381:Rats; D011919:Rats, Inbred Strains; D014280:Triglycerides / Q000737:chemistry / Q000145:classification / Q000633:toxicity
chemical_list: D002273:Carcinogens; D004075:Diglycerides; D005227:Fatty Acids; D014280:Triglycerides